HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Morishita Selected Research

NF-kappaB decoy

7/2001NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model.
6/2001Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
8/2000Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats.
5/2000Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Morishita Research Topics

Disease

11Cardiovascular Diseases (Cardiovascular Disease)
01/2004 - 01/2000
11Hyperplasia
01/2004 - 02/2000
9Inflammation (Inflammations)
07/2011 - 08/2000
6Neoplasms (Cancer)
03/2008 - 06/2000
6Vascular System Injuries
01/2004 - 04/2000
6Arteriosclerosis
10/2000 - 02/2000
5Ischemia
03/2002 - 02/2001
5Peripheral Arterial Disease
03/2002 - 02/2001
4Hypoxia (Hypoxemia)
03/2008 - 05/2000
4Fibrosis (Cirrhosis)
08/2006 - 07/2000
3Chronic Limb-Threatening Ischemia
04/2011 - 01/2000
3Atherosclerosis
10/2004 - 09/2000
3Hypertension (High Blood Pressure)
10/2004 - 10/2000
3Vascular Diseases (Vascular Disease)
12/2001 - 06/2001
2Schizophrenia (Dementia Praecox)
10/2010 - 10/2010
2Cardiomyopathies (Cardiomyopathy)
08/2006 - 12/2001
2Abdominal Aortic Aneurysm
04/2006 - 07/2005
2Renal Insufficiency (Renal Failure)
06/2004 - 12/2001
2Reperfusion Injury
10/2001 - 05/2000
2Myocardial Ischemia (Ischemic Heart Diseases)
08/2001 - 01/2000
2Melanoma (Melanoma, Malignant)
07/2001 - 06/2000
2Neointima
02/2001 - 03/2000
2Myocardial Infarction
01/2001 - 01/2000
1Mental Disorders (Mental Disorder)
01/2016
1Pathologic Processes
07/2011
1Intracranial Aneurysm (Cerebral Aneurysm)
07/2011
1Ulcer
04/2011
1Thromboangiitis Obliterans (Buerger's Disease)
04/2011
1Neurodevelopmental Disorders
10/2010
1Rupture
09/2010
1Alzheimer Disease (Alzheimer's Disease)
04/2008
1Cognitive Dysfunction
04/2008
1Parkinson Disease (Parkinson's Disease)
12/2006
1Wounds and Injuries (Trauma)
08/2006
1Metabolic Diseases (Metabolic Disease)
06/2006
1Osteoporosis
06/2006
1Diabetic Nephropathies (Diabetic Nephropathy)
06/2004
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2003
1Hypertriglyceridemia
11/2002
1Hypercholesterolemia
11/2002
1Diabetes Mellitus
10/2002
1Eczema
09/2002
1Atopic Dermatitis (Atopic Eczema)
09/2002

Drug/Important Bio-Agent (IBA)

14Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2011 - 01/2000
11DNA (Deoxyribonucleic Acid)IBA
04/2011 - 05/2000
10OligodeoxyribonucleotidesIBA
06/2006 - 02/2000
10NF-kappa B (NF-kB)IBA
09/2002 - 05/2000
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2008 - 01/2000
7Transcription Factors (Transcription Factor)IBA
04/2006 - 07/2000
5Proteins (Proteins, Gene)FDA Link
07/2011 - 03/2000
5OligonucleotidesIBA
04/2006 - 07/2000
5Liposomes (Liposome)IBA
06/2004 - 11/2000
5ElementsIBA
01/2004 - 08/2000
5CytokinesIBA
11/2001 - 07/2000
4Angiotensin IIIBA
06/2004 - 02/2000
4Messenger RNA (mRNA)IBA
10/2001 - 05/2000
4NF-kappaB decoyIBA
07/2001 - 05/2000
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2011 - 08/2000
3Antisense OligonucleotidesIBA
01/2004 - 07/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2003 - 01/2000
3LuciferasesIBA
11/2001 - 06/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2001 - 07/2000
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2001 - 02/2000
2DysbindinIBA
10/2010 - 10/2010
2prostacyclin synthetase (prostacyclin synthase)IBA
08/2006 - 10/2000
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2004 - 11/2001
2Epoprostenol (Prostacyclin)FDA LinkGeneric
10/2002 - 10/2000
2Cardiovascular AgentsIBA
12/2001 - 07/2000
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2001 - 05/2000
2pyrrolidine dithiocarbamic acidIBA
07/2001 - 05/2000
2Phosphotransferases (Kinase)IBA
06/2001 - 05/2000
2Pharmaceutical PreparationsIBA
06/2001 - 06/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2000 - 08/2000
2Catalytic RNA (Ribozymes)IBA
09/2000 - 07/2000
1SeptinsIBA
01/2016
1EP2 Subtype Prostaglandin E ReceptorsIBA
07/2011
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2011
1ProstaglandinsIBA
07/2011
1Prostaglandin Receptors (Prostaglandin Receptor)IBA
07/2011
1Prostaglandin-E SynthasesIBA
07/2011
1Prostaglandins EIBA
07/2011
1Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
07/2011
1Proto-Oncogene Protein c-ets-1IBA
09/2010
1A-Form DNA (A-DNA)IBA
03/2008
1Carrier Proteins (Binding Protein)IBA
03/2008
1CollagenIBA
08/2006
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
06/2006
1CalciumIBA
10/2004
1Nifedipine (Adalat)FDA LinkGeneric
10/2004
1Glucose (Dextrose)FDA LinkGeneric
06/2004
1Apolipoproteins E (ApoE)IBA
11/2002
1Ointments (Pastes)IBA
09/2002

Therapy/Procedure

13Therapeutics
03/2008 - 01/2000
4Intramuscular Injections
04/2011 - 02/2001
2Catheters
02/2003 - 04/2002
2Injections
11/2002 - 07/2001
2Heart Transplantation (Grafting, Heart)
05/2000 - 02/2000
1Limb Salvage
04/2011
1Drug Therapy (Chemotherapy)
04/2011
1Oral Administration
10/2002